Prostatitis
31
0
0
16
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.9%
4 terminated out of 31 trials
80.0%
-6.5% vs benchmark
35%
11 trials in Phase 3/4
31%
5 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (31)
FOsfomycin for Male Urinary Tract Infection
TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Effect of Graminex on Infertility Related to Male Accessory Glands Inflammation
CBD-based Therapy to Attenuate Non-bacterial Prostatitis Symptoms
Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
Therapeutic Study of Prostatitis With Elevated PSA
Etiology Study of Prostatitis
Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis
Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy
Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Chemokine Mechanisms in Chronic Pelvic Pain
Applying Pulsed Radiofrequency to the Pudendal Nerve Bilaterally Vs Its Application to Sacral Nerve Roots S2,3 and 4 Bilaterally in Chronic Prostatitis
Microbiome of Urologic Chronic Pelvic Pain Syndrome
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)
Linkage Analysis in Interstitial Cystitis
Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
Efficacy of Gralise® for Chronic Pelvic Pain
2013 Annual National Digital Rectal Exam (DRE) Day Study